Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer’s Disease

Alexa Pichet Binette,Étienne Vachon-Presseau,John Morris,Randall Bateman,Tammie Benzinger,D. Louis Collins,Judes Poirier,John C.S. Breitner,Sylvia Villeneuve,Dominantly Inherited Alzheimer Network,Ricardo Allegri,Fatima Amtashar,Randy Bateman,Tammie Benzinger,Sarah Berman,Courtney Bodge,Susan Brandon,William Brooks,Jill Buck,Virginia Buckles,Sochenda Chea,Jasmeer Chhatwal,Patricio Chrem,Helena Chui,Jake Cinco,Jack Clifford,Carlos Cruchaga,Mirelle D‘Mello,Tamara Donahue,Jane Douglas,Noelia Edigo,Nilufer Erekin-Taner,Anne Fagan,Marty Farlow,Angela Farrar,Howard Feldman,Gigi Flynn,Nick Fox,Erin Franklin,Hisako Fujii,Cortaiga Gant,Samantha Gardener,Bernardino Ghetti,Alison Goate,Jill Goldman,Brian Gordon,Neill Graff-Radford,Julia Gray,Jenny Gurney,Jason Hassenstab,Mie Hirohara,David Holtzman,Russ Hornbeck,Siri Houeland DiBari,Takeshi Ikeuchi,Snezana Ikonomovic,Gina Jerome,Mathias Jucker,Celeste Karch,Kensaku Kasuga,Takeshi Kawarabayashi,William Klunk,Robert Koeppe,Elke Kuder-Buletta,Christoph Laske,Jae-Hong Lee,Johannes Levin,Daniel Marcus,Ralph Martins,Neal Scott Mason,Colin Masters,Denise Maue-Dreyfus,Eric McDade,Lucy Montoya,Hiroshi Mori,John Morris,Akem Nagamatsu,Katie Neimeyer,James Noble,Joanne Norton,Richard Perrin,Marc Raichle,John Ringman,Jee Hoon Roh,Stephen Salloway,Peter Schofield,Hiroyuki Shimada,Tomoyo Shiroto,Mikio Shoji,Wendy Sigurdson,Hamid Sohrabi,Paige Sparks,Kazushi Suzuki,Laura Swisher,Kevin Taddei,Jen Wang,Peter Wang,Mike Weiner,Mary Wolfsberger,Chengjie Xiong,Xiong Xu,PREVENT-AD Research Group,Angela Tam,Anne Labonté,Alexa Pichet Binette,Anne-Marie Faubert,Axel Mathieu,Cécile Madjar,Charles Edouard Carrier,Christian Dansereau,Christina Kazazian,Claude Lepage,Cynthia Picard,David Maillet,Diane Michaud,Doris Couture,Doris Dea,Claudio Cuello,Alan Barkun,Alan Evans,Blandine Courcot,Christine Tardif,Clément Debacker,Clifford R. Jack,David Fontaine,David S. Knopman,Gerhard Maultaup,Jamie Near,Jeannie-Marie Leoutsakos,Jean-Robert Maltais,Jason Brandt,Jens Pruessner,John C. Morris,John C.S. Breitner,Judes Poirier,Laksanun Cheewakriengkrai,Lisa-Marie Münter,Louis Collins,Mallar Chakravarty,Mark A. Sager,Marina Dauar-Tedeschi,Mark Eisenberg,Natasha Rajah,Paul Aisen,Joanne Toussaint,Pedro Rosa-Neto,Pierre Bellec,Penelope Kostopoulos,Pierre Etienne,Pierre N. Tariot,Pierre Orban,Reisa A. Sperling,Rick Hoge,Ronald G. Thomas,Serge Gauthier,Suzanne Craft,Sylvia Villeneuve,Thomas J. Montine,Vasavan Nair,Véronique Bohbot,Vinod Venugopalan,Vladimir Fonov,Yasser Ituria-Medina,Zaven S. Khachaturian,Eduard Teigner,Elena Anthal,Elsa Yu,Fabiola Ferdinand,Galina Pogossova,Ginette Mayrand,Guerda Duclair,Guylaine Gagné,Holly Newbold-Fox,Illana Leppert,Isabelle Vallée,Jacob W. Vogel,Jennifer Tremblay-Mercier,Joanne Frenette,Josée Frappier,Justin Kat,Justin Miron,Karen Wan,Laura Mahar,Leopoldina Carmo,Louise Théroux,Mahsa Dadar,Marianne Dufour,Marie-Elyse Lafaille-Magnan,Melissa Appleby,Mélissa Savard,Miranda Tuwaig,Mirela Petkova,Pierre Rioux,Pierre-François Meyer,Rana El-Khoury,Renee Gordon,Renuka Giles,Samir Das,Seqian Wang,Shirin Tabrizi,Sulantha Mathotaarachchi,Sylvie Dubuc,Tanya Lee,Thomas Beaudry,Valérie Gervais,Véronique Pagé,Julie Gonneaud,Gülebru Ayranci,Tharick A. Pascoal,René Desautels,Fatiha Benbouhoud,Eunice Farah Saint-Fort,Sander C.J. Verfaillie,Sarah Farzin,Alyssa Salaciak,Stephanie Tullo,Etienne Vachon-Presseau,Leslie-Ann Daoust,Theresa Köbe,Nathan Spreng,Melissa McSweeney,Nathalie Nilsson,Morteza Pishnamazi,Christophe Bedetti,William (Bill) Brooks,William (Bill) Klunk
DOI: https://doi.org/10.1016/j.biopsych.2020.01.023
IF: 12.81
2021-04-01
Biological Psychiatry
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Major prevention trials for Alzheimer's disease (AD) are now focusing on multi-domain lifestyle interventions. However, the exact combination of behavioral factors related to AD pathology remains unclear. In two cohorts of cognitively unimpaired individuals at risk of AD, we examined which combinations of personality traits, neuropsychiatric symptoms, and cognitive lifestyle (years of education or lifetime cognitive activity) related to the pathological hallmarks of AD, amyloid-beta and <em>tau</em> deposits.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Some 115 older adults with a parental or multiple-sibling family history of sporadic AD (PREVENT-AD cohort) underwent amyloid and <em>tau</em> positron emission tomography (PET) and answered several questionnaires related to behavioral attributes. Separately, we studied 117 mutation carriers from the Dominantly Inherited AD (DIAN) cohort with amyloid PET and behavioral data. Using partial least squares analysis, we identified latent variables relating amyloid or <em>tau</em> pathology with combinations of personality traits, neuropsychiatric symptoms, and cognitive lifestyle.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>In PREVENT-AD, lower neuroticism, neuropsychiatric burden and higher education were associated with less amyloid deposition (p=0.014). Lower neuroticism and neuropsychiatric features, along with higher measures of openness and extraversion, were related to less <em>tau</em> deposition (p=0.006). In DIAN, lower neuropsychiatric burden and higher education were also associated with less amyloid (p=0.005). The combination of these factors accounted for up to 14% of AD pathology.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>In the preclinical phase of both sporadic and autosomal dominant AD, multiple behavioral features were associated with AD pathology. These results may suggest potential pathways by which multi-domain interventions might help delay AD onset or progression.</p>
neurosciences,psychiatry
What problem does this paper attempt to address?